Make us your home page

UF research shows promise in finding cure for citrus greening


The researchers' tools were chemistry class standards — glass flasks, test tubes and pipettes — but the task performed may be part of a revolutionary cure for the scourge of the state's orange industry: citrus greening.

The test tube in a tiny lab at the Lake Alfred Citrus Research and Education Center held dissolved citrus tissue. The fluid dripping into it from a pipette carried an enzyme that can snip genes like scissors, along with strands of RNA to guide the enzyme to precise genetic targets.

They are part of a gene-editing tool called CRISPR, which is so efficient it has been loosely compared to the "find and replace" function of a word-processing program.

Nian Wang, the University of Florida professor leading this CRISPR research team at Lake Alfred, said the tool could cut decades from reaching the holy grail of citrus research — producing varieties immune from the disease that has devastated Florida's most iconic industry.

"Come back in two or three years, and I'll show you a tree," Wang said.

The benefits of CRISPR are not just that it can eliminate genes that make citrus vulnerable to greening. It can replace them with other genes from the same plant, rather than from jellyfish or spinach, as has been the case with some previous genetically modified organisms.

Mostly because CRISPR products don't borrow genes from other plants or animals, the U.S. Department of Agriculture ruled last spring that they won't face the same regulation as earlier generations of GMOs.

"If there is any kind of regulatory approval needed, it's going to be much shorter and much cheaper," said Dr. Michael Rogers, director of the UF-run research center east of Lakeland.

The method could also provide growers fighting to hang on using a variety of expensive, lower-tech tools — including the regular replanting of groves — with a product more palatable to the public.

"To knock out a specific gene without introducing a new gene would solve the challenge facing growers and would be more acceptable for consumers," said Larry Black, a grower from Fort Meade.

The impact of greening, a bacterial disease carried by small insects called psyllids, can be seen in the many groves of dead or dying trees surrounding the research center on the northern edge of the Central Florida citrus belt.

The annual production of oranges in Florida, 242 million boxes in the 2003-2004 season, dropped to 81.6 million boxes last season. And on Wednesday, the USDA released a dire prediction for the coming harvest, 70 million boxes — though some of that predicted decline is blamed on heavy rains last spring that stripped blossoms from trees before they were able to bear fruit.

CRISPR is based on a virus-fighting system in bacteria that uses DNA, the building blocks of chromosomes, and ribonucleic acid, which transmits genetic messages.

In the 1980s, researchers noticed that bacteria stockpile what seemed to be stray bits of DNA called "clustered regularly interspaced short palindromic repeats," or CRISPR.

They later found that these strands of genetic material match DNA of their viral enemies — and that bacteria used them as models to create RNA that takes enzymes on seek-and-destroy missions against the virus's DNA.

In recent years, scientists learned to duplicate this process and apply it to other organisms.

"All biologists have to do is feed (the enzymes) the right sequence, called a guide RNA, and boom, you can cut and paste bits of DNA sequence into the genome wherever you want," the tech website, Gizmodo, reported in 2015

The process has been touted as a possible cure for a wide range of genetic maladies in humans, and Wang has already shown it can work in citrus, producing a variety of grapefruit resistant to an earlier menace of the industry, citrus canker.

Proof of the industry's confidence in Wang's research is an initial $500,000 grant from the grower-funded Citrus Development and Research Foundation. This was followed by a $1 million line item included in the 2015-16 state budget by the Florida Legislature, which pledged to support his work for three years.

But Wang also said his project is more time-consuming than the hype over CRISPR might suggest, requiring a team of six researchers and tools far more sophisticated than test tubes and flasks, including sequencing equipment and "gene guns" that shoot DNA into cells.

The vast array of genes in the citrus genome means that some are very similar, which in turn means that the RNA might lock on to a beneficial gene rather than one the researchers are targeting.

"You have to analyze the genome very carefully to make sure you only target the bad guys and not the good guys," Wang said.

Then there's the laborious process of identifying which genes are, in fact, the "bad guys" — the ones that make the trees susceptible to greening.

This process is further complicated by the systemic nature of the disease, said Fred Gmitter, another UF professor at Lake Alfred who is conducting CRISPR research, and who earlier helped map the genome of the sweet orange.

"It's not like you have a single gene for susceptibility and you just knock that out and everything is fine," Gmitter said.

"Anything you can imagine metabolically happening in the plant, there are changes brought about by this disease."

And even after all these "susceptibility genes" are identified and deactivated, Wang said, his team must surmount the obstacle that always faces researchers of slow-growing fruit trees: A wait of years to determine whether the disease-resistant tree has retained all the qualities — especially the ability to produce sweet, marketable fruit — that growers demand.

But even that process is hastened by CRISPR, because the process gives researchers detailed knowledge of the modified tree's genetics before it goes into the ground.

"I think this is one of the most promising technologies out there," Rogers said.

Contact Dan DeWitt at Follow @ddewitttimes.

UF research shows promise in finding cure for citrus greening 10/17/16 [Last modified: Monday, October 17, 2016 4:57am]
Photo reprints | Article reprints

© 2017 Tampa Bay Times


Join the discussion: Click to view comments, add yours

  1. Trigaux: How Moffitt Cancer's M2Gen startup won $75 million from Hearst


    TAMPA — A Moffitt Cancer Center spin-off that's building a massive genetic data base of individual patient cancer information just caught the attention of a deep-pocketed health care investor.

    Richard P. Malloch is the president of Hearst Business Media, which is announcing a $75 million investment in M2Gen, the for-profit cancer informatics unit spun off by Tampa's Moffitt Cancer Center. Malloch's job is to find innovative investments for the Hearst family fortune. A substantial amount has been invested in health care, financial and the transportation and logistics industries.
  2. Three-hour police standoff ends, thanks to a cigarette


    TAMPA — A man threatening to harm himself was arrested by Tampa police on Tuesday after a three-hour standoff.

  3. Another Hollywood nursing home resident dies. It's the 9th in post-Irma tragedy.

    State Roundup

    The Broward County Medical Examiner's office is investigating another death of a resident of the Rehabilitation Center at Hollywood Hills — the ninth blamed on the failure of a cooling system that became a stifling deathtrap three days after Irma hit.

    Carlos Canal, pictured at 47 years old, came to Miami from Cuba in 1960. Above is his citizenship photo. [Courtesy of Lily Schwartz]
  4. Despite Hurricane Irma, Hillsborough remains on pace to unlock hotel tax that could pay for Rays ballpark


    TAMPA — Despite the threat of a catastrophic storm, it was business as usual at many Hillsborough County hotels in the days before Hurricane Irma bore down on the Tampa Bay region.

    The Grand Hyatt near TIA closed during Hurricane Irma, but many other Hillsborough hotels were open and saw an influx.
  5. New Graham-Cassidy health care plan stumbles under opposition from governors


    WASHINGTON — The suddenly resurgent Republican effort to undo the Affordable Care Act was dealt a blow on Tuesday when a bipartisan group of governors came out against a proposal gaining steam in the Senate.

    Sen. Lindsey Graham, R-S.C., joined by, from left, Sen. Roy Blunt, R-Mo., Majority Whip John Cornyn, R-Texas, Sen. John Barrasso, R-Wyo., Sen. Bill Cassidy, R-La., Senate Majority Leader Mitch McConnell, R-Ky., and Sen. John Thune, R-S.D., speaks to reporters as he pushes a last-ditch effort to uproot former President Barack Obama's health care law, at the Capitol in Washington, Tuesday, Sept. 19, 2017. To win, 50 of the 52 GOP senators must back it -- a margin they failed to reach when the chamber rejected the effort in July. [/J. Scott Applewhite | Associated Press]